-
-
Call more information
660-596-2224 -
ASA Monitor May 2024, Vol. 88, 27. The CEREGLIDE™ 71 Intermediate Catheter with TruCourse™ from Cerenovus, Inc., a division of Johnson & Johnson MedTech, is now available in the United States. The catheter is designed for the revascularization of acute ischemic stroke patients and facilitates direct aspiration and compatible stent retriever delivery, aiding in restoring blood […]
Read MoreAuthors: Dibash Kumar Das, PhD; Steven L. Shafer, MD, FASA ASA Monitor May 2024, Vol. 88, 1–5. Since its introduction almost 40 years ago, propofol has been adopted worldwide as the intravenous anesthetic of choice, with alternatives such as ketamine and etomidate limited to unusual indications. However, propofol has several common adverse effects, including pain on injection […]
Read MoreASA Monitor May 2024, Vol. 88, 10. Your next patient is a 55-year-old man with chronic kidney disease who is presenting for kidney transplantation from a deceased donor. Your resident asks about the use of intravenous (I.V.) balanced crystalloid solution for perioperative volume resuscitation. According to a recent study, which of the following MOST likely describes […]
Read MoreAuthor: Vishal Uppal, MBBS, MSc, FRCA ASA Monitor May 2024, Vol. 88, 1–9. When compared with general anesthesia (GA), patients undergoing surgery solely under peripheral nerve blocks (PNBs) are more likely to have improved short-term postoperative pain control, less nausea and vomiting, early discharge from the postanesthesia care unit and hospital, and overall improved patient satisfaction […]
Read MoreAuthor: David P. Martin, MD, PhD, FASA ASA Monitor May 2024, Vol. 88, 7–8. The largest group of committees and editorial boards within ASA resides in the Division of Scientific Affairs, comprising the sections on Publications, Clinical Care, Subspecialties, Education and Research, and the Annual Meeting. Last year in this column, space allowed us to review […]
Read More